Other Event

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event

Ignite Creation Date: 2025-12-25 @ 4:11 AM
Ignite Modification Date: 2025-12-26 @ 3:10 AM
NCT ID: NCT02587520
Term: Myalgia
Organ System: Musculoskeletal and connective tissue disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 18.0
Notes: None
Study: NCT02587520
Study Brief: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 42 42 79 View
EG001 35 35 71 View
EG002 38 38 77 View
EG003 42 42 77 View
EG004 52 52 75 View
EG005 38 38 75 View
EG006 32 32 76 View
EG007 29 29 73 View
EG008 35 35 76 View
EG009 36 36 76 View
EG010 39 39 76 View
EG011 28 28 72 View
EG012 12 12 77 View
EG013 21 21 73 View
EG014 31 31 78 View
EG015 23 23 72 View
EG016 23 23 76 View
EG017 18 18 78 View